Intravitreal triamcinolone acetonide for refractory diabetic macular oedema

Intravitreal versus sub-Tenon triamcinolone acetonide for refractory diffuse diabetic macular oedema

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema Refractory to Intravitreal Ranibizumab. Nine-month Results

The Purpose of this study was to evaluate the efficacy of IVTA as rescue therapy in patients with DME refractory to intravitreal ranibizumab. This is a prospective interventional non-comparative study that included diabetic patients with persistent CSME and associated visual loss despite previous treatment with intravitreal ranibizumab. Main outcome measures were improvement of BCVA 3 Snellen l...

Triamcinolone Acetonide for the Treatment of Diabetic Macular Oedema

Diabetic macular oedema is a major cause of severe visual loss whose pathogenesis appears to be complex and multifactorial. For many years laser photocoagulation has been the standard of care for the treatment of this condition. Emerging pharmacologic approaches are being evaluated through randomised controlled trials. Triamcinolone acetonide has been proposed as a promising option, due to its ...

Intravitreal triamcinolone acetonide for the treatment of diffuse diabetic macular oedema--a case report.

INTRODUCTION Although laser photocoagulation is the primary treatment for diabetic macular oedema, treatment of eyes with diffuse macular oedema has been disappointing. Intravitreal injection of steroids is being investigated for the treatment of diabetic macular oedema. Preliminary results indicate that steroid injections do improve macular oedema, but it is not clear if they improve visual ac...

Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

AIM To evaluate the effect of different doses of intravitreal triamcinolone acetonide on diffuse diabetic macular oedema. METHODS The prospective, randomised, double masked, clinical interventional study included 27 eyes (27 patients) with diffuse diabetic macular oedema. They were randomly divided into three study groups receiving an intravitreal injection of filtered triamcinolone acetonide...